Ieq Capital LLC Buys New Stake in Cigna Group $CI

Ieq Capital LLC bought a new stake in Cigna Group (NYSE:CI) during the second quarter, HoldingsChannel.com reports. The fund bought 39,713 shares of the health services provider’s stock, valued at approximately $10,948,000.

Several other hedge funds have also recently added to or reduced their stakes in CI. Assetmark Inc. grew its position in Cigna Group by 10.0% in the first quarter. Assetmark Inc. now owns 65,662 shares of the health services provider’s stock valued at $17,515,000 after acquiring an additional 5,963 shares during the period. Mystic Asset Management Inc. bought a new position in shares of Cigna Group during the second quarter valued at $2,808,000. HighTower Advisors LLC boosted its stake in shares of Cigna Group by 402.7% in the 2nd quarter. HighTower Advisors LLC now owns 354,398 shares of the health services provider’s stock valued at $97,701,000 after purchasing an additional 283,897 shares in the last quarter. KBC Group NV boosted its stake in shares of Cigna Group by 6.4% in the 2nd quarter. KBC Group NV now owns 380,034 shares of the health services provider’s stock valued at $104,768,000 after purchasing an additional 22,978 shares in the last quarter. Finally, Handelsbanken Fonder AB grew its holdings in shares of Cigna Group by 12.1% in the 2nd quarter. Handelsbanken Fonder AB now owns 82,825 shares of the health services provider’s stock worth $22,833,000 after purchasing an additional 8,960 shares during the last quarter. Institutional investors and hedge funds own 86.99% of the company’s stock.

Cigna Group Stock Up 0.6%

Shares of NYSE:CI opened at $276.19 on Friday. Cigna Group has a 12 month low of $239.51 and a 12 month high of $315.47. The company’s 50-day moving average price is $284.20 and its two-hundred day moving average price is $281.38. The company has a quick ratio of 0.76, a current ratio of 0.76 and a debt-to-equity ratio of 0.68. The firm has a market cap of $72.98 billion, a P/E ratio of 11.43, a P/E/G ratio of 0.95 and a beta of 0.29.

Cigna Group (NYSE:CI) last announced its earnings results on Thursday, July 30th. The health services provider reported $7.78 earnings per share for the quarter, topping analysts’ consensus estimates of $7.60 by $0.18. Cigna Group had a net margin of 2.27% and a return on equity of 19.75%. The company had revenue of $70.04 billion during the quarter, compared to the consensus estimate of $70.14 billion. During the same period in the previous year, the firm posted $7.20 earnings per share. The company’s revenue was up 6.7% on a year-over-year basis. Cigna Group has set its FY 2026 guidance at 30.450- EPS. As a group, research analysts forecast that Cigna Group will post 30.51 EPS for the current fiscal year.

Cigna Group Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Wednesday, September 23rd. Investors of record on Tuesday, September 8th will be issued a $1.56 dividend. The ex-dividend date of this dividend is Tuesday, September 8th. This represents a $6.24 dividend on an annualized basis and a dividend yield of 2.3%. Cigna Group’s dividend payout ratio (DPR) is currently 25.82%.

Analyst Upgrades and Downgrades

A number of equities research analysts recently issued reports on the stock. Royal Bank Of Canada increased their target price on shares of Cigna Group from $333.00 to $337.00 and gave the stock an “outperform” rating in a research report on Friday, May 1st. Robert W. Baird set a $362.00 price target on shares of Cigna Group in a research report on Friday, July 31st. UBS Group boosted their target price on Cigna Group from $375.00 to $400.00 and gave the stock a “buy” rating in a report on Friday, May 22nd. Barclays increased their price target on Cigna Group from $304.00 to $310.00 and gave the stock an “equal weight” rating in a research report on Friday, July 31st. Finally, Jefferies Financial Group cut Cigna Group from a “buy” rating to a “hold” rating and dropped their price target for the company from $336.00 to $307.00 in a report on Tuesday, August 4th. Fifteen research analysts have rated the stock with a Buy rating and seven have given a Hold rating to the company. According to MarketBeat.com, the company has an average rating of “Moderate Buy” and an average price target of $339.45.

Insider Activity at Cigna Group

In other news, insider Nicole S. Jones sold 19,436 shares of Cigna Group stock in a transaction on Tuesday, August 4th. The stock was sold at an average price of $276.27, for a total value of $5,369,583.72. Following the completion of the sale, the insider directly owned 27,256 shares of the company’s stock, valued at approximately $7,530,015.12. This trade represents a 41.63% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CAO Jamie G. Kates sold 899 shares of the business’s stock in a transaction on Friday, June 12th. The stock was sold at an average price of $298.61, for a total value of $268,450.39. Following the sale, the chief accounting officer owned 2,368 shares of the company’s stock, valued at approximately $707,108.48. The trade was a 27.52% decrease in their position. The SEC filing for this sale provides additional information. Insiders sold a total of 23,012 shares of company stock valued at $6,386,550 in the last 90 days. 0.60% of the stock is currently owned by corporate insiders.

About Cigna Group

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.